Mercury Laboratories Ltd
NSE: BSE: 538964
₹760
(0%)
Mon, 19 Oct 2026, 01:12 am
Market Cap (in Cr)91.2
PE Ratio21.90
Dividend0.46
Health Technology
Pharmaceuticals: Major
24.5KMercury Laboratories Financials
| Particulars | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 277.77M | 267.57M | 334.62M | 414.50M | 411.91M | 475.17M | 480.27M | 518.68M | 555.04M | 572.69M | 686.01M | 579.24M | 753.34M | 755.59M | 751.01M |
| Gross profit | 92.55M | 93.96M | 119.32M | 147.26M | 146.29M | 172.95M | 171.78M | 165.01M | 164.42M | 173.48M | 228.52M | 169.35M | 240.19M | 235.42M | 226.05M |
| Operating expenses (excl. COGS) | -61.48M | -64.19M | -81.63M | -91.22M | -99.01M | -118.73M | -113.80M | -134.35M | -122.22M | -129.02M | -145.51M | -120.73M | -177.57M | -171.89M | -183.33M |
| Selling/general/admin expenses, total | -59.66M | -62.42M | -79.57M | -87.80M | -91.20M | -105.91M | -105.92M | -122.83M | -115.63M | -112.85M | -130.07M | -102.77M | -158.32M | -144.68M | -150.60M |
| Research & development | — | — | — | — | — | — | -465.85K | -656.58K | -160.44K | -415.74K | -25.82K | -241.00K | -85.00K | -245.00K | 0 |
| Selling/general/admin expenses, other | -59.66M | -62.42M | -79.57M | -87.80M | -91.20M | -105.91M | -105.46M | -122.17M | -115.47M | -112.44M | -130.05M | -102.53M | -158.23M | -144.44M | -150.60M |
| Other operating expenses, total | -1.82M | -1.78M | -2.06M | -3.41M | -7.82M | -12.82M | -7.88M | -11.52M | -6.58M | -16.16M | -15.43M | -17.96M | -19.25M | -27.21M | -32.73M |
| Operating income | 31.07M | 29.76M | 37.69M | 56.05M | 47.28M | 54.22M | 57.98M | 30.67M | 42.20M | 44.46M | 83.01M | 48.62M | 62.62M | 63.53M | 42.72M |
| Non-operating income, total | -214.11K | 3.55M | 534.39K | -8.12M | -1.23M | -4.86M | -9.04M | -6.11M | -1.69M | -1.17M | -3.92M | 1.72M | 11.83M | 5.67M | 3.90M |
| Interest expense, net of interest capitalized | -3.88M | -3.16M | -3.57M | -14.68M | -8.88M | -9.79M | -8.92M | -9.07M | -10.88M | -8.17M | -6.41M | -4.46M | -3.62M | -3.83M | -5.48M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 3.83M | 5.68M | 4.10M | 6.57M | 7.65M | 4.93M | 197.42K | 2.96M | 8.69M | 7.21M | 7.48M | 6.95M | 15.74M | 9.50M | 9.37M |
| Non-operating interest income | 463.51K | 1.60M | 630.53K | 590.62K | 637.81K | 636.13K | 672.67K | 820.01K | 689.01K | 688.18K | 574.66K | 884.00K | 1.24M | 1.20M | 944.00K |
| Miscellaneous non-operating expense | 3.37M | 4.07M | 3.47M | 5.97M | 7.02M | 4.29M | -475.25K | 2.14M | 8.00M | 6.52M | 6.90M | 6.07M | 14.50M | 8.30M | 8.43M |
| Unusual income/expense | -159.49K | 1.03M | 0 | 0 | 0 | 0 | -316.07K | — | 498.04K | -209.33K | -4.99M | -768.00K | -292.00K | 0 | 0 |
| Pretax income | 30.86M | 33.31M | 38.23M | 47.93M | 46.05M | 49.36M | 48.94M | 24.56M | 40.51M | 43.29M | 79.09M | 50.34M | 74.45M | 69.20M | 46.62M |
| Taxes | -10.32M | -10.24M | -12.83M | -15.72M | -12.92M | -10.13M | -21.91M | -4.43M | -12.14M | -11.01M | -25.71M | -14.72M | -18.66M | -12.66M | -15.17M |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | 0 | 0 | 0 | 0 | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 20.54M | 23.07M | 25.40M | 32.22M | 33.13M | 39.23M | 27.03M | 20.13M | 28.36M | 32.28M | 53.37M | 35.62M | 55.79M | 56.54M | 31.45M |
| Net income | 20.54M | 23.07M | 25.40M | 32.22M | 33.13M | 39.23M | 27.03M | 20.13M | 28.36M | 32.28M | 53.37M | 35.62M | 55.79M | 56.54M | 31.45M |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 20.54M | 23.07M | 25.40M | 32.22M | 33.13M | 39.23M | 27.03M | 20.13M | 28.36M | 32.28M | 53.37M | 35.62M | 55.79M | 56.54M | 31.45M |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 33.86M | 32.72M | 40.91M | 64.98M | 59.08M | 66.06M | 70.87M | 45.41M | 58.48M | 63.15M | 102.22M | 73.15M | 87.45M | 91.68M | 71.48M |
| EBIT | 31.07M | 29.76M | 37.69M | 56.05M | 47.28M | 54.22M | 57.98M | 30.67M | 42.20M | 44.46M | 83.01M | 48.62M | 62.62M | 63.53M | 42.72M |
| Total operating expenses | -246.70M | -237.81M | -296.93M | -358.45M | -364.64M | -420.96M | -422.29M | -488.01M | -512.85M | -528.23M | -603.00M | -530.62M | -690.72M | -692.06M | -708.29M |
| Prepaid expenses | — | — | — | — | 31.25M | 45.34M | 1.13M | 866.35K | 1.44M | 465.17K | 452.63K | 1.14M | 2.22M | 996.00K | 1.16M |
| Deferred income, current | 915.59K | 1.23M | 1.35M | 3.69M | 2.59M | 6.10M | 4.54M | 5.77M | 2.05M | 8.31M | 4.83M | 11.81M | 3.97M | 5.72M | 2.83M |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 446.00K | 526.00K | 526.00K | 7.41M |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 6.58M | 6.53M | 10.30M | 15.28M | 15.77M | 12.16M | 18.06M | 15.89M | 18.22M | 17.40M | 21.28M | 25.39M | 22.96M | 21.10M | 22.63M |
| Deferred income, non-current | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | -2.11M | -2.09M | -2.09M | -2.09M | -2.09M | -2.17M | -2.17M | -2.17M | -2.17M | -2.17M | -4.20M | -2.40M | -4.20M | -4.20M | -4.20M |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
